BrexitDB.com
Home
Themes
Types
DB
About
Showing:
◈ news
×
◈ Recardio
×
|<
<-
->
:
New
Old
Date
A-Z
Z-A
Popular
Page 1 (1-1)
Recardio puts the brakes on new heart drug trials in U.K. over Brexit concerns
03/10/2018
San Francisco-based clinical-stage life science company Recardio is halting clinical trials in the U.K. of a new heart drug due to concerns about Brexit and how new drugs will be approved.
https://www.fiercebiotech.com/
news
clinical trials
health
medicine
Recardio
|<
<-
->
:
New
Old
Date
A-Z
Z-A
Popular
Page 1 (1-1)